We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
MedQ facilitates the transition of clinics from paper to digital assessments and remote patient management, offering access to various questionnaires, including PROMs, which gauge patients' health status and care experience. Through electronic data capture, MedQ enhances efficiency and time savings. It operates as a SaaS company, providing an online platform for registered healthcare professionals to use, offering over 150 patient questionnaires and assessments, integration with electronic medical records, and the ability to manage patients remotely.
days to go: Expired investment: Withheld
MGN Builders Merchants is a well-established, profitable, and a fast-growing builders merchants and skip hire based in London and Essex. It offers same or next day delivery on thousands of building products kept in stock at all times. Having served 50,000+ customers in 2018 (81k EBITDA), the company's client base includes small to medium-sized companies, private developers and DIY customers. In the last three years, the company has trebled its revenue from £2.5m in 2016 to £7m by January 2019, achieving an almost 100% sales increase YoY. MGN is raising funding to accelerate its rapid growth plans, expand its team, start selling online, and launch concrete delivery service to capture UK's £34bn construction supplied wholesale market.
days to go: Expired investment: £114,260
Milbotix, a healthtech start-up, supported by the Alzheimer's Society and the UK Dementia Research Institute, is driven by its innovative product SmartSocks™. This wearable technology aims to assist individuals with dementia facing communication challenges and their caregivers. Globally, the number of people with dementia is increasing significantly, reaching 78 million by 2030 and 139 million by 2050. Half of those diagnosed with dementia encounter challenging behavioral symptoms due to distress. Early distress management not only enhances well-being but also helps prevent escalating behavioral issues. SmartSocks™ utilize sensors and artificial intelligence to notify dementia caregivers about early signs of pain and anxiety in their patients.
days to go: Expired investment: £220,780
Mindful uses blockchain, artificial intelligence (AI) and video technologies to deliver mental health recovery programmes for 8 to 25-year-olds. With the help of their technology, the therapists work with families and schools to change the way of providing mental health services. The company has a powerful management team experience in business, healthcare and education. Mindful is currently running a pilot project and is signing up schools in the West Midlands. The company is signing partnerships with 6 Multi Academy Trusts with further trust to sign > 50 schools.
days to go: Expired investment: £91,850
Moltex Energy is developing and advancing a next-generation nuclear reactor that is capable of generating clean electricity at a much economical cost than fossil fuels. This objective will be realistic through Moltex Energy's fully patented and protected technology based on Stable Salt Reactor (SSR), the first fundamentally new nuclear technology. The company shares good relationships with the UK, the USA and the Canadian government. Moltex Energy aims to transform the world's energy market by designing intrinsically safe nuclear reactors that deliver clean energy at a lower cost than coal or gas, which is the key to provide affordable energy and make a meaningful impact on climatic.
days to go: Expired investment: £5,728,799
Narvitas Medical Devices have created a device called the Lapdome. The Lapdome utilises negative pressure to create working space for the surgical tools during laparoscopic surgery. It does this without the danger of coming near any of the underlying vital organs.
days to go: Expired investment: £153
Liquid supplements are a faster acting and a more efficient way for the body to absorb key active ingredients than taking pills. Our scientists have developed formulations involving leading active ingredients such as collagen in order to create the perfect wellness solution in every bottle. Each LQ bottle is packed full of 9 or more active ingredients all in one easy to drink, daily 50 m bottle.
days to go: Expired investment: £355,000
Offering a more affordable fitness class solution through training small groups and providing unparalleled client care with 1-on-1 personal training sessions. Outrivals has grown rapidly since launching 3 years ago near the famous Old Street Roundabout and are raising funds to open 2 new sites, with plans to have a portfolio of 15 branches over the next 5 years. The company has a high retention rate, with a client life cycle averaging one year.
days to go: Expired investment: £88,450
OvuSense is a women's health monitoring platform offering continuous insights into the reproductive cycle. With over 45,000 users and 10 patents, they aim to expand through partnerships, starting with a large IVF clinic chain. Addressing underdiagnosed health issues, their platform provides accurate cycle monitoring, health screening, and treatment tracking. Backed by institutional investors, OvuSense stands out for its predictive capabilities and accuracy in ovulation tracking, empowering women's fertility control.
days to go: Expired investment: £169,920
PathCloud aims to assemble the global clinical diagnostics resources and data and make them safely available and helpful. The company has created and tested one of the first scalable clinical diagnostics management platforms. It currently has 20,000 clinicians partner networks and 92 registered clinicians. Additionally, it has a network across 48 counties, has over 100 providers, over 3500 diagnostics tests registered and over 10,000 patients by partner telemedicine networks. These funds will be used to gain a significant portion of diagnostics supplier agreements towards the scaling objective, increase efforts towards the international markets and NHS and pursue telemedicine networks.
days to go: Expired investment: £81,720
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph